Pharmacogenetics of CYP3A5 in Pediatric Patients With Eosinophilic Esophagitis. [PDF]
Noel-MacDonnell J +7 more
europepmc +1 more source
Shared decision making in Eosinophilic esophagitis: Integrating physician and patient perspectives. [PDF]
Ryan KA +6 more
europepmc +1 more source
The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management. [PDF]
Bertin L +14 more
europepmc +1 more source
Outcomes of Dupilumab Treatment in Refractory Eosinophilic Esophagitis: A Retrospective Cohort Study from Saudi Arabia. [PDF]
Alnajjar A +9 more
europepmc +1 more source
Molecular and immunological heterogeneity of eosinophilic esophagitis: Insights and subtyping. [PDF]
Twum E, Baranova A, Ullah A.
europepmc +1 more source
Eosinophilic esophagitis is associated with increased risk of allergic conjunctivitis: a multicenter cohort study. [PDF]
Lishinsky-Fischer N +4 more
europepmc +1 more source
Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis. [PDF]
Sharlin CS +13 more
europepmc +1 more source
Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis. [PDF]
Nguyen N, Bauer M.
europepmc +1 more source
Less Can Be Enough: Sustained Remission of Pediatric Eosinophilic Esophagitis With Low-Frequency Dupilumab. [PDF]
Scatigna G +4 more
europepmc +1 more source
Pediatric eosinophilic esophagitis among children attending a tertiary hospital in Nairobi, Kenya: a case series. [PDF]
Mwangi L +4 more
europepmc +1 more source

